<p><h1>New-Born Screening Market Provides Detailed Segmentation of this Market based on Type, Application, and Region and Forecast for the Period from 2023 - 2030</h1></p><p><strong>New-Born Screening Market Analysis and Latest Trends</strong></p>
<p><p>New-born screening is the process of screening infants shortly after birth to detect any genetic, metabolic, or functional disorders that may not be apparent in the early stages. It involves collecting a small blood sample from the baby's heel, which is then sent to a laboratory to analyze and identify any potential health issues. The goal of new-born screening is to detect and treat conditions as early as possible, preventing long-term health problems or even death.</p><p>The global new-born screening market is anticipated to experience substantial growth in the coming years. Factors such as the increasing prevalence of genetic disorders, advancements in screening technologies, and rising awareness about the importance of early diagnosis are driving the market growth. Additionally, government initiatives and mandates for new-born screening programs in various countries are further propelling the market.</p><p>Moreover, the development of non-invasive screening methods and the integration of automation and digitalization into screening processes are shaping the latest trends in the new-born screening market. Non-invasive screening methods, such as using saliva or urine samples instead of blood, are gaining popularity due to their convenience and reduced discomfort for infants. Furthermore, the implementation of automation and digital technologies streamlines the screening process, enhances accuracy, and reduces turnaround time for results.</p><p>The market analysis suggests that the new-born screening market is projected to grow at a CAGR of 11.7% during the forecast period. This growth can be attributed to the increasing demand for early diagnosis and intervention to prevent severe health complications in infants. The expanding market scope presents opportunities for market players to introduce new screening technologies, expand their geographical presence, and collaborate with healthcare institutions to provide comprehensive screening solutions.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp; <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1158305">https://www.reliableresearchreports.com/enquiry/request-sample/1158305</a></strong></p>
<p>&nbsp;</p>
<p><strong>New-Born Screening Major Market Players</strong></p>
<p><p>The new-born screening market is highly competitive and is characterized by the presence of several key players. Some of the major players in the market include GE Healthcare, Trivitron Healthcare, AB Sciex, Perkinelmer, Bio-Rad Laboratories, Agilent Technologies, Medtronic, Masimo, Waters, and Natus Medical.</p><p>GE Healthcare is a global leader in medical technology and offers a wide range of products and services in the healthcare industry. The company has a strong presence in the new-born screening market with its advanced screening technologies and solutions. GE Healthcare has a solid track record of innovation and has been actively involved in research and development activities to enhance its product offerings. The company has experienced significant market growth over the years, driven by advancements in technologies and increasing awareness about the importance of early diagnosis and treatment in new-borns. The market size for GE Healthcare in the new-born screening segment is significant, as the company caters to a global customer base.</p><p>Another key player in the market is Perkinelmer, a leading provider of products, services, and solutions for diagnostics, life sciences, and environmental markets. The company has a strong presence in the new-born screening market and offers a wide range of screening products and solutions. Perkinelmer has a long history of innovation and has been at the forefront of new-born screening advancements. The company has experienced consistent market growth, driven by a focus on research and development and strategic collaborations with healthcare providers and organizations. The market size for Perkinelmer in the new-born screening segment is substantial, as the company has a strong customer base and a global presence.</p><p>In terms of sales revenue, the specific figures for the listed companies are not provided. However, it is important to note that the new-born screening market is estimated to be valued at over $1 billion globally. This indicates the potential market size and growth opportunities for the companies operating in this space.</p><p>Overall, the new-born screening market is highly competitive, with several key players vying for market share. Companies such as GE Healthcare and Perkinelmer have a strong presence in the market, driven by their innovative product offerings and focus on research and development. The market size for the new-born screening market is significant, indicating the growing importance of early diagnosis and treatment in new-borns.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For New-Born Screening Manufacturers?</strong></p>
<p><p>The new-born screening market is experiencing significant growth due to various factors such as rising awareness about early detection of diseases, favorable government policies, and advancements in technology. The market data indicates a steady increase in the number of babies being screened annually. Additionally, the market is witnessing a trend towards the adoption of point-of-care testing and genetic screening. In terms of the future outlook, the market is expected to continue growing at a substantial rate, driven by the increasing prevalence of genetic disorders and the development of innovative screening technologies. Furthermore, collaborations between research institutes and biotechnology companies are expected to further drive market growth.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report: <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1158305">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1158305</a></strong></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The New-Born Screening Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Tandem Mass Spectrometry</li><li>Pulse Oximetry Screening Technology</li><li>DNA-Based Assays</li><li>Hearing Screen Technology</li><li>Others</li></ul></p>
<p><p>Newborn screening is a process conducted shortly after birth to identify any potential health conditions in newborn babies. Tandem Mass Spectrometry involves analyzing the baby's blood sample to detect metabolic disorders. Pulse Oximetry Screening Technology measures oxygen levels in the blood to identify heart or lung problems. DNA-based assays involve examining the baby's DNA for genetic disorders. Hearing Screen Technology checks for hearing loss in newborns. "Others" market includes additional screening methods such as screening for rare diseases, cystic fibrosis, hormonal disorders, etc. These technologies help in early detection and timely intervention, potentially saving the baby's life or preventing long-term complications.</p></p>
<p><strong>Purchase this Report:&nbsp;<a href="https://www.reliableresearchreports.com/purchase/1158305">https://www.reliableresearchreports.com/purchase/1158305</a></strong></p>
<p>&nbsp;</p>
<p><strong>The New-Born Screening Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hospitals</li><li>Clinics</li><li>Nursing Homes</li><li>Others</li></ul></p>
<p><p>The newborn screening market application encompasses various healthcare settings such as hospitals, clinics, nursing homes, and other medical facilities. These settings offer the necessary infrastructure and expertise to conduct newborn screening tests. Hospitals play a crucial role as they are the primary healthcare centers where many newborns are delivered. Clinics and nursing homes also cater to the screening needs of newborns, ensuring timely and accurate detection of congenital disorders. Other medical facilities, including specialized centers and diagnostic laboratories, contribute to expanding the reach of newborn screening services.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the New-Born Screening Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The global new-born screening market is anticipated to experience significant growth in the regions of North America (NA), Asia-Pacific (APAC), Europe, the United States of America (USA), and China. NA is expected to dominate the market due to its advanced healthcare infrastructure and increasing awareness about the benefits of early detection and treatment. APAC and Europe are also projected to exhibit substantial growth owing to the rising prevalence of genetic and metabolic disorders. The market share percentages for these regions are expected to vary but are estimated to be approximately NA (40%), APAC (25%), Europe (20%), USA (10%), and China (5%).</p></p>
<p><strong>Purchase this Report: <a href="https://www.reliableresearchreports.com/purchase/1158305">https://www.reliableresearchreports.com/purchase/1158305</a></strong></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;<a href="https://www.reliableresearchreports.com/enquiry/request-sample/1158305">https://www.reliableresearchreports.com/enquiry/request-sample/1158305</a></strong></p>
<p><strong></strong></p>
<p><p><a href="https://www.linkedin.com/pulse/optical-fiber-array-market-size-share-global-analysis-lkgpe/">Optical Fiber Array Market</a></p><p><a href="https://www.linkedin.com/pulse/pin-laser-diode-market-insights-players-forecast-till-2030-s7iue/">PIN Laser Diode Market</a></p><p><a href="https://github.com/lilstefpacute/Market-Research-Report-List-1/blob/main/aloe-vera-based-drinks-market.md">Aloe Vera-Based Drinks Market</a></p><p><a href="https://github.com/rexevange/Market-Research-Report-List-1/blob/main/multi-assay-screening-systems-market.md">Multi-Assay Screening Systems Market</a></p><p><a href="https://medium.com/@agree.gain.spray/parallel-capacitor-market-size-growth-forecast-2023-2030-802f65506bb8">Parallel Capacitor Market</a></p></p>